Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors

You may be eligible for inclusion in the above clinical trial, which has study centres in Arizona and California in the USA. The aim of the study is to examine the effects of the novel treatment tinostamustine in those patients with certain types of cancer who have failed previous therapies.

If you wish to be considered for this study, you should contact your healthcare professional and they will assess your suitability and if appropriate, refer you to the centre undertaking the trial.

To take part in this trial, you will have to meet certain requirements, which include: Age ≥18 years, that you are not currently pregnant and/or breastfeeding and that you have not recently participated in a clinical trial.